Drosocin-1

General Information


DRACP ID  DRACP00476

Peptide Name   Drosocin-1

Sequence  GKPRPYSPRPTSHPRPIRV

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Drosophila melanogaster; Drosophila simulans

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma Not active up to 600 µg/ml Not available Not available 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma Not active up to 601 µg/ml Not available Not available 1

Hemolytic Activity  Mouse erythrocytes: <10% Hemolysis=100 µM; Pig erythrocytes: <10% Hemolysis=100 µM; Human erythrocytes: Not active up to 600 µg/ml

Normal (non-cancerous) Cytotoxicity  CEM-SS cells: 50% Cell death>45.5 µM; HEK293: Not active up to 600 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00476

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C98H160N34O24

Absent amino acids  ACDEFLMNQW

Common amino acids  P

Mass  251976

Pl  12.51

Basic residues  6

Acidic residues  0

Hydrophobic residues  2

Net charge  6

Boman Index  -6950

Hydrophobicity  -157.89

Aliphatic Index  35.79

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  82.78

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24164265

Title  Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity

Doi 10.2174/09298665113206660105

Year  2014

Literature 2

Pubmed ID 31001677

Title  The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum

Doi 10.1007/s00436-019-06305-x

Year  2019

Literature 3

Pubmed ID 20086159

Title  Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database

Doi 10.1128/AAC.01448-09

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.